All Stories

  1. All Three in One: A Cohort, Proteomics, and Mendelian Randomization Biomarker Study
  2. A multicenter, open‐label, single‐arm trial of the long‐term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE‐02)
  3. Effects of HIF-PHD inhibitors in kidney development
  4. Renal outcomes with sodium‐glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases
  5. GRP78 Contributes to the Beneficial Effects of SGLT2 Inhibitor on Proximal Tubular Cells in DKD
  6. Inhibition of Amino Acids Influx into Proximal Tubular Cells Improves Lysosome Function in Diabetes
  7. Role of Semaphorin 3A in Kidney Development and Diseases
  8. Semaphorin 3A Signaling in Kidney Development and Diseases
  9. Role of glycosylphosphatidylinositol‐anchored high‐density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes
  10. Retroperitoneal Solid Pseudopapillary Tumor Mimicking Adrenal Malignant Tumor in a 67-Year-Old Man
  11. NDUFS4 Regulates Cristae Remodeling in Diabetic Kidney Disease
  12. Genome-wide association study of the risk of chronic kidney disease and kidney-related traits in the Japanese population: J-Kidney-Biobank
  13. Suramin prevents the development of diabetic kidney disease by inhibiting NLRP3 inflammasome activation in KK‐Ay mice
  14. Cover Image, Volume 24, Issue 12
  15. Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study
  16. The association between hypothyroidism and proteinuria in patients with chronic kidney disease: a cross-sectional study
  17. Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan
  18. Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice
  19. Cilostazol Attenuates AngII-Induced Cardiac Fibrosis in apoE Deficient Mice
  20. Effects of Wnt-β-Catenin Signaling and Sclerostin on the Phenotypes of Rat Pheochromocytoma PC12 Cells
  21. Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA)
  22. Simulation for ultrasound‐guided renal biopsy using boiled egg
  23. A case of recurrent IgG4-related disease successfully treated with belimumab after remission of systemic lupus erythematosus
  24. Analysis of Inflammatory Cytokines and Estimated Glomerular Filtration Rate Decline in Japanese Patients with Diabetic Kidney Disease: A Pilot Study
  25. Potential Strategies for Kidney Regeneration With Stem Cells: An Overview
  26. Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells
  27. Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation
  28. Tankyrase represses autoinflammation through the attenuation of TLR2 signaling
  29. Vasohibin-1 has α-tubulin detyrosinating activity in glomerular podocytes
  30. Circulating GPIHBP1 levels and microvascular complications in patients with type 2 diabetes: A cross-sectional study
  31. Silica-associated systemic lupus erythematosus with lupus nephritis and lupus pneumonitis
  32. Prevalence of Chronic Kidney Disease and Variation of Its Risk Factors by the Regions in Okayama Prefecture
  33. The Association of Postprandial Triglyceride Variability with Renal Dysfunction and Microalbuminuria in Patients with Type 2 Diabetic Mellitus: A Retrospective and Observational Study
  34. Adipocyte-Specific Inhibition of Mir221/222 Ameliorates Diet-Induced Obesity Through Targeting Ddit4
  35. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
  36. Mesenchymal stem cells-derived extracellular vesicles as ‘natural’ drug delivery system for tissue regeneration
  37. Development of Urinary Diagnostic Biomarker for IgA Nephropathy by Lectin Microarray
  38. Management of corticosteroid-dependent eosinophilic interstitial nephritis
  39. Corrigendum: Upregulation of Mir342 in Diet-Induced Obesity Mouse and the Hypothalamic Appetite Control
  40. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice
  41. Semaporin3A inhibitor ameliorates renal fibrosis through the regulation of JNK signaling
  42. Corrigendum: Upregulation of Mir342 in Diet-Induced Obesity Mouse and the Hypothalamic Appetite Control
  43. Sodium–Glucose Cotransporter 2 Inhibitors Work as a “Regulator” of Autophagic Activity in Overnutrition Diseases
  44. SGLT2 Inhibitors vs Other Glucose-Lowering Drugs: Kidney Outcomes in Real-World Clinical Practice
  45. Blood concentrations of tacrolimus upon conversion from rabeprazole to vonoprazan in renal transplant recipients: Correlation with cytochrome P450 gene polymorphisms
  46. Commentary on Intraglumerular dysfunction predicts kidney failure in the type 2 diabetes
  47. Author Correction: Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2
  48. Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases
  49. Presence of decoy cells for 6 months on urine cytology efficiently predicts BK virus nephropathy in renal transplant recipients
  50. Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments
  51. Current Diagnosis and Management of Primary Chylomicronemia
  52. Upregulation of Mir342 in Diet-Induced Obesity Mouse and the Hypothalamic Appetite Control
  53. Kidney cyst infection through a fistula between bladder and retroperitoneal abscess in a polycystic kidney disease patient
  54. Total vascular resistance, augmentation index, and augmentation pressure increase in patients with peripheral artery disease
  55. Diagnosis and Management of Sitosterolemia 2021
  56. Association of blood pressure and renal outcome in patients with chronic kidney disease; a post hoc analysis of FROM-J study
  57. Corrigendum: RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
  58. Successful deceased donor kidney transplantation to a recipient with a history of COVID-19 treatment
  59. Feasible kidney donation with living marginal donors, including diabetes mellitus
  60. The effect of Humanitude care methodology on improving empathy: a six-year longitudinal study of medical students in Japan
  61. ABO Blood Incompatibility Positively Affects Early Graft Function: Single-Center Retrospective Cohort Study
  62. RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
  63. Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2)
  64. Orexin A Enhances Pro-Opiomelanocortin Transcription Regulated by BMP-4 in Mouse Corticotrope AtT20 Cells
  65. Endonuclease increases efficiency of osteoblast isolation from murine calvariae
  66. Fisetin Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Macrophage
  67. The resolution of immunofluorescent pathological images affects diagnosis for not only artificial intelligence but also human
  68. Acute Kidney Injury Caused by Evans Syndrome with Systemic Lupus Erythematosus and Systemic Sclerosis
  69. A Vaspin–HSPA1L complex protects proximal tubular cells from organelle stress in diabetic kidney disease
  70. Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2
  71. Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study
  72. Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy
  73. Deletion of Mir223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Faslpr/lpr Mice
  74. Granulomatosis with polyangiitis with obstructive pneumonia progressing to hypertrophic pachymeningitis
  75. Current Status of Familial LCAT Deficiency in Japan
  76. MicroRNAs as Biomarkers for Nephrotic Syndrome
  77. Vasohibin-2 Aggravates Development of Ascending Aortic Aneurysms but not Abdominal Aortic Aneurysms nor Atherosclerosis in ApoE-Deficient Mice
  78. Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis
  79. Dynamin 1 is important for microtubule organization and stabilization in glomerular podocytes
  80. Low‐dose rituximab induction therapy is effective in immunological high‐risk renal transplantation without increasing cytomegalovirus infection
  81. Inhibition of interleukin-6 signaling attenuates aortitis, left ventricular hypertrophy and arthritis in interleukin-1 receptor antagonist deficient mice
  82. Multicentric Reticulohistiocytosis in a Patient with Hand Contracture
  83. Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis
  84. Tubulointerstitial Nephritis Cases With IgM-Positive Plasma Cells
  85. Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia
  86. Tubulointerstitial Nephritis and Uveitis Caused by Sjögren Syndrome Without Dryness
  87. Deep Learning Could Diagnose Diabetic Nephropathy with Renal Pathological Immunofluorescent Images
  88. Takayasu phlebitis
  89. Adult kidney stem/progenitor cells contribute to regeneration through the secretion of trophic factors
  90. Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury
  91. The Protective Effect of Chlorogenic Acid on Vascular Senescence via the Nrf2/HO-1 Pathway
  92. Podocytopathy as ‘stand-alone’ involvement in systemic lupus erythematosus: a case report
  93. Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury
  94. Sodium Glucose Co-Transporter 2 Inhibitor Ameliorates Autophagic Flux Impairment on Renal Proximal Tubular Cells in Obesity Mice
  95. Recovery from hypoxemia and Hypercapnia following noninvasive pressure support ventilation in a patient with statin-associated necrotizing myopathy: a case report
  96. Association of explanatory histological findings and urinary protein and serum creatinine levels at renal biopsy in lupus nephritis: a cross-sectional study
  97. Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer
  98. Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report
  99. Targeting angiogenesis and lymphangiogenesis in kidney disease
  100. Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan
  101. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials
  102. Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome
  103. Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases
  104. Damage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registry
  105. A novel homoplasmic mitochondrial DNA mutation (m.13376T>C, p.I347T) of MELAS presenting characteristic medial temporal lobe atrophy
  106. Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
  107. Simultaneous development of IgA vasculitis and eosinophilic granulomatosis with polyangiitis
  108. HIV-associated Immune Complex Kidney Disease with C3-dominant Deposition Induced by HIV Infection after Treatment of IgA Nephropathy
  109. The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study
  110. Renal tubular injury exacerbated by vasohibin-1 deficiency in a murine cisplatin-induced acute kidney injury model
  111. Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis
  112. Report of health checkup system for chronic kidney disease in general population in Okayama city: effect of health guidance intervention on chronic kidney disease outcome
  113. Urine 5MedC, a Marker of DNA Methylation, in the Progression of Chronic Kidney Disease
  114. Combination of Renal Angioplasty and Angiotensin-converting-enzyme Inhibitor Can Reduce Proteinuria in Patients with Bilateral Renal Artery Disease
  115. Capnocytophaga canimorsus peritonitis diagnosed by mass spectrometry in a diabetic patient undergoing peritoneal dialysis: a case report
  116. Withdrawal: Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy.
  117. Inhibitory Effects of Tofogliflozin on Cardiac Hypertrophy in Dahl Salt-Sensitive and Salt-Resistant Rats Fed a High-Fat Diet
  118. Impaired mental health status in patients with chronic kidney disease is associated with estimated glomerular filtration rate decline
  119. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease
  120. Parathyroid Lipoadenoma: A Pitfall in Preoperative Localization
  121. Exogenous Vasohibin-2 Exacerbates Angiotensin II-Induced Ascending Aortic Dilation in Mice
  122. MON-485 Effects of Orexin A on Prolactin Production by Regulating BMP-4 Activity in Rat Pituitary Lactotorope Cells
  123. Reply
  124. Orexin A modulates prolactin production by regulating BMP-4 activity in rat pituitary lactotorope cells
  125. Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4+ T cells
  126. Development of Hypertrophic Pachymeningitis in a Patient With Antineutrophil Cytoplasmic Antibody–Negative Eosinophilic Granulomatosis With Polyangiitis
  127. Hemoptysis Originating from the Bronchial Artery in Takayasu Arteritis with Ulcerative Colitis
  128. Multiple nodular pulmonary amyloidosis in a patient with rheumatoid arthritis
  129. Thrombocytosis as a prognostic factor in polymyalgia rheumatica: characteristics determined from cluster analysis
  130. GPIHBP1 autoantibody syndrome during interferon β1a treatment
  131. Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity
  132. Abdominal aortic aneurysm in aged population
  133. Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports
  134. Antineutrophil cytoplasmic antibody-positive familial Mediterranean fever and hyperthyroidism
  135. The clinical efficacy of angiotensin II type1 receptor blockers on inflammatory markers in patients with hypertension: a multicenter randomized-controlled trial; MUSCAT-3 study
  136. The relationship between repeated measurement of casual and 24-h urinary sodium-to-potassium ratio in patients with chronic kidney disease
  137. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus
  138. Diabetic nephropathy is associated with frailty in patients with chronic hemodialysis
  139. An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin
  140. Lymphoproliferative disease in a patient with Takayasu arteritis and ulcerative colitis
  141. Correction: Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus–Derived T Cells
  142. Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy
  143. Reply
  144. Chronic kidney disease is associated with carotid atherosclerosis and symptomatic ischaemic stroke
  145. Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression
  146. Cluster Analysis Using Anti–Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis
  147. Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1
  148. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model
  149. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model
  150. Cilostazol Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E–Deficient Mice
  151. Estrogen-related receptor α is essential for maintaining mitochondrial integrity in cisplatin-induced acute kidney injury
  152. Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells
  153. Serum cystatin C is an independent biomarker associated with the renal resistive index in patients with chronic kidney disease
  154. Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab
  155. Cavernous Transformation and Granulomatous Epididymis in Behçet Disease
  156. Peripheral artery disease is associated with frailty in chronic hemodialysis patients
  157. The KCNQ1 gene polymorphism as a shared genetic risk for rheumatoid arthritis and chronic periodontitis in japanese adults: A pilot case-control study
  158. Development of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal disease
  159. Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: A randomized controlled trial
  160. Urine Trefoil Factors as Prognostic Biomarkers in Chronic Kidney Disease
  161. The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
  162. High calcium enhances the expression of double-stranded RNA sensors and antiviral activity in epidermal keratinocytes
  163. The effects of non-surgical periodontal treatment on glycemic control, oxidative stress balance and quality of life in patients with type 2 diabetes: A randomized clinical trial
  164. Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia
  165. Primary peritoneal carcinosarcoma in a dialysis patient
  166. Cardiovocal syndrome (Ortner syndrome) associated with secondary pulmonary arterial hypertension in a patient with mixed connective tissue disease
  167. Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice
  168. Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
  169. Regulatory role of melatonin and BMP-4 in prolactin production by rat pituitary lactotrope GH3 cells
  170. The level of urinary semaphorin3A is associated with disease activity in patients with minimal change nephrotic syndrome
  171. Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus–Derived T Cells
  172. A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy
  173. Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis
  174. Reprogramming of metabolism in immune-mediated cells
  175. Nodular lesions in diabetic nephropathy: Collagen staining and renal prognosis
  176. Practical efficacy of olmesartan versus azilsartan in patients with hypertension
  177. Antiangiogenic Therapy for Diabetic Nephropathy
  178. Arterial Stiffness is an Independent Risk Factor for Anemia After Percutaneous Native Kidney Biopsy
  179. Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
  180. Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
  181. Melatonin regulates catecholamine biosynthesis by modulating bone morphogenetic protein and glucocorticoid actions
  182. Occurrence of Dermatomyositis Immediately after Mastectomy Subsequent to Severe Chemotherapeutic Drug Eruption
  183. Sustained Tubulointerstitial Inflammation in Kidney with Severe Leptospirosis
  184. The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab
  185. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents
  186. Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease
  187. Chronic Kidney Disease Is Positively and Diabetes Mellitus Is Negatively Associated with Abdominal Aortic Aneurysm
  188. ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism
  189. The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn’s disease
  190. Salt and sugar: Bad company
  191. Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose‐induced oxidative stress in type 1 diabetic mice
  192. Acute idiopathic blue fingers: a young man with Achenbach's syndrome
  193. Development of intracerebral hemorrhage in the short-term clinical course of a patient with microscopic polyangiitis without neurological symptoms at diagnosis: an autopsy case
  194. Antiobesity Action of ACAM by Modulating the Dynamics of Cell Adhesion and Actin Polymerization in Adipocytes
  195. Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis
  196. <i>CDH13</i> Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass
  197. Bilateral Abducens Nerve Palsy due to Idiopathic Intracranial Hypertension as an Initial Manifestation of Systemic Lupus Erythematosus
  198. Risk Factors for the Requirement of Antenatal Insulin Treatment in Gestational Diabetes Mellitus
  199. Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis
  200. Innate immunity in diabetes and diabetic nephropathy
  201. The efficacy of add-on tacrolimus for minor flare in patients with systemic lupus erythematosus: a retrospective study
  202. Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetes
  203. Risk factors for the development of glucocorticoid-induced diabetes mellitus
  204. Identification of Circulating miR-101, miR-375 and miR-802 as Biomarkers for Type 2 Diabetes
  205. Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial
  206. Autoimmune pancreatitis and minimal change nephrotic syndrome: an unusual association?
  207. <i>ADIPOQ</i> polymorphisms are associated with insulin resistance in Japanese women
  208. Structural design and synthesis of arylalkynyl amide-type peroxisome proliferator-activated receptor γ (PPARγ)-selective antagonists based on the helix12-folding inhibition hypothesis
  209. Cognitive and affective functions in diabetic patients associated with diabetes-related factors, white matter abnormality and aging
  210. Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
  211. Pemt Deficiency Ameliorates Endoplasmic Reticulum Stress in Diabetic Nephropathy
  212. Nuclear Hormone Receptor Expression in Mouse Kidney and Renal Cell Lines
  213. Sarcoid-like lung granulomas in a hemodialysis patient treated with a dipeptidyl peptidase-4 inhibitor
  214. Serum vaspin levels are associated with physical activity or physical fitness in Japanese: a pilot study
  215. Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats
  216. Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice
  217. The Chemiexcitation of the Chemiluminescence of Lophine Peroxide Anions via a Partially Cyclic Transition State
  218. Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism
  219. Erratum
  220. Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray
  221. Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes
  222. Visceral Adipose Tissue-derived Serine Proteinase Inhibitor Inhibits Apoptosis of Endothelial Cells as a Ligand for the Cell-Surface GRP78/Voltage-dependent Anion Channel Complex
  223. Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease
  224. Telmisartan Attenuates Diabetic Nephropathy by Suppressing Oxidative Stress in <b><i>db/db</i></b> Mice
  225. <i>NUDT3</i> rs206936 is associated with body mass index in obese Japanese women
  226. Erratum
  227. Replication Study of 15 Recently Published Loci for Body Fat Distribution in the Japanese Population
  228. The serum vaspin levels are reduced in Japanese chronic hemodialysis patients
  229. Activation of Liver X Receptor Inhibits Osteopontin and Ameliorates Diabetic Nephropathy
  230. Vaspin Is an Adipokine Ameliorating ER Stress in Obesity as a Ligand for Cell-Surface GRP78/MTJ-1 Complex
  231. Inflammation and the pathogenesis of diabetic nephropathy
  232. Case of emphysematous cholecystitis in a patient with type 2 diabetes mellitus associated with schizophrenia
  233. Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice
  234. Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan
  235. Serum Vaspin Concentrations Are Closely Related to Insulin Resistance, and rs77060950 atSERPINA12Genetically Defines Distinct Group with Higher Serum Levels in Japanese Population
  236. The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial
  237. The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO)
  238. Association between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomography
  239. RXR antagonism induces G0/G1 cell cycle arrest and ameliorates obesity by up‐regulating the p53–p21$^{\rm{Cip1}}$ pathway in adipocytes
  240. Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes
  241. A Case of Type 2 Diabetes and Metastatic Liver Cancer Exhibiting Hypercholesterolemia with Abnormal Lipoproteins
  242. Impact of circulating vaspin levels on metabolic variables in elderly twins
  243. Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women
  244. Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population
  245. Computed tomography analysis of the association between the SH2B1 rs7498665 single-nucleotide polymorphism and visceral fat area
  246. Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations
  247. Icodextrin Increases Technique Survival Rate in Peritoneal Dialysis Patients with Diabetic Nephropathy by Improving Body Fluid Management: A Randomized Controlled Trial
  248. Activation of Peroxisome Proliferator–Activated Receptor δ Inhibits Streptozotocin-Induced Diabetic Nephropathy Through Anti-Inflammatory Mechanisms in Mice
  249. Discovery of Genes Related to Diabetic Nephropathy in Various Animal Models by Current Techniques
  250. High Glucose Increases Metallothionein Expression in Renal Proximal Tubular Epithelial Cells
  251. 3. Obesity and New Secretory Factors. 1) Vaspin.
  252. Intercellular adhesion molecule-1 plays a critical role in glomerulosclerosis after subtotal nephrectomy
  253. Insufficient control of morning home blood pressure in Japanese patients with hypertension associated with diabetes mellitus
  254. Peramivir for Severe Influenza Infection in a Patient with Diabetic Nephropathy
  255. P-Selectin Glycoprotein Ligand-1 Deficiency Is Protective Against Obesity-Related Insulin Resistance
  256. Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1, FTO and MC4R and their effect on visceral fat area in the Japanese population
  257. In Vivo Delivery of Gremlin siRNA Plasmid Reveals Therapeutic Potential against Diabetic Nephropathy by Recovering Bone Morphogenetic Protein-7
  258. Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes
  259. The Usefulness of Super-Selective Computed Tomography Angiography (CTA) for Diagnosing and Localizing a Small Insulinoma
  260. Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population
  261. Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins
  262. Historical chronology of basic and clinical research in diabetic nephropathy and contributions of Japanese scientists
  263. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy
  264. Enhanced interaction between focal adhesion and adherens junction proteins: Involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement
  265. Screening of 336 single-nucleotide polymorphisms in 85 obesity-related genes revealed McKusick–Kaufman syndrome gene variants are associated with metabolic syndrome
  266. Rap1b GTPase Ameliorates Glucose-Induced Mitochondrial Dysfunction
  267. Bilateral dystonia in type 1 diabetes: a case report
  268. Collectrin Is Involved in the Development of Salt-Sensitive Hypertension by Facilitating the Membrane Trafficking of Apical Membrane Proteins via Interaction With Soluble N -Ethylmaleiamide-Sensitive Factor Attachment Pro...
  269. INSIG2 gene rs7566605 polymorphism is associated with severe obesity in Japanese
  270. Comparison of serum uric acid levels between Japanese with and without metabolic syndrome
  271. Procollagen C-proteinase enhancer-1 (PCPE-1) interacts with β2-microglobulin (β2-m) and may help initiate β2-m amyloid fibril formation in connective tissues
  272. Variations in the FTO gene are associated with severe obesity in the Japanese
  273. Vaspin: a novel serpin with insulin-sensitizing effects
  274. Diabetic Nephropathy: Mechanisms of Renal Disease Progression
  275. Collectrin, a homologue of ACE2, its transcriptional control and functional perspectives
  276. Edaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells
  277. Glycated albumin levels predict long‐term survival in diabetic patients undergoing haemodialysis
  278. Association of single-nucleotide polymorphisms in MTMR9 gene with obesity
  279. Comparison of ventilatory threshold and exercise habits between Japanese men with and without metabolic syndrome
  280. Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients
  281. The Role for HNF-1β-Targeted Collectrin in Maintenance of Primary Cilia and Cell Polarity in Collecting Duct Cells
  282. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activation
  283. Functional Single-Nucleotide Polymorphisms in the Secretogranin III (SCG3) Gene that Form Secretory Granules with Appetite-Related Neuropeptides Are Associated with Obesity
  284. Changes of gene expression profiles in macrophages stimulated by angiotensin II — Angiotensin II induces MCP-2 through AT1-receptor
  285. Errata
  286. Macrophage Scavenger Receptor-A–Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation
  287. Hemophagocytic Syndrome Associated with Fatal Veno-Occlusive Disease in the Liver
  288. Severe Hypoglycemia Induced by IGF-II Producing Non-Islet Cell Tumor
  289. Thiazolidinediones Ameliorate Diabetic Nephropathy via Cell Cycle–Dependent Mechanisms
  290. Elevated Serum Monocyte Chemoattractant Protein‐4 and Chronic Inflammation in Overweight Subjects
  291. Therapeutic Approach for Diabetic Nephropathy Using Gene Delivery of Translocase of Inner Mitochondrial Membrane 44 by Reducing Mitochondrial Superoxide Production
  292. Relationship between Metabolic Syndrome and Cigarette Smoking in the Japanese Population
  293. Relationship between Metabolic Syndrome and Proteinuria in the Japanese Population
  294. The Application of Synthetic hANP in Diabetic Nephropathy With Nephrotic Syndrome
  295. Modulation of renal-specific oxidoreductase/ myo -inositol oxygenase by high-glucose ambience
  296. Serum Interleukin-18 Levels Are Associated With Nephropathy and Atherosclerosis in Japanese Patients With Type 2 Diabetes
  297. The HNF-1 target Collectrin controls insulin exocytosis by SNARE complex formation
  298. Galectin-9 Inhibits Glomerular Hypertrophy in db/db Diabetic Mice via Cell-Cycle–Dependent Mechanisms
  299. Methotrexate Prevents Renal Injury in Experimental Diabetic Rats via Anti-Inflammatory Actions
  300. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats
  301. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients
  302. Gene Delivery of Tim44 Reduces Mitochondrial Superoxide Production and Ameliorates Neointimal Proliferation of Injured Carotid Artery in Diabetic Rats
  303. Renal-specific oxidoreductase biphasic expression under high glucose ambience during fetal versus neonatal development
  304. Clinical features of non-diabetic renal diseases in patients with type 2 diabetes
  305. Cell Biology of Diabetic Kidney Disease
  306. Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity
  307. Pathological Roles of Advanced Glycation End Product Receptors SR‐A and CD36
  308. Hyperglycemia: its imminent effects on mammalian nephrogenesis
  309. Identification of adipocyte adhesion molecule (ACAM), a novel CTX gene family, implicated in adipocyte maturation and development of obesity
  310. Sulfated Hyaluronic Acid, a Potential Selectin Inhibitor, Ameliorates Experimentally Induced Crescentic Glomerulonephritis
  311. The Critical Role of Src Homology Domain 2–Containing Tyrosine Phosphatase-1 in Recombinant Human Erythropoietin Hyporesponsive Anemia in Chronic Hemodialysis Patients
  312. Intravenous Vitamin D Therapy Reduces PTH-(1–84)/Large C Fragments Ratio in Chronic Hemodialysis Patients
  313. Changes in serum leptin concentrations in overweight Japanese men after exercise
  314. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats
  315. Update of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis
  316. Cerebroside Sulfotransferase Deficiency Ameliorates L-selectin-dependent Monocyte Infiltration in the Kidney after Ureteral Obstruction
  317. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
  318. Daily exercise lowers blood pressure and reduces visceral adipose tissue areas in overweight Japanese men
  319. Pathogenesis of IgA nephropathy
  320. Serum bFGF levels are reduced in Japanese overweight men and restored by a 6-month exercise education
  321. Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes
  322. Gene Regulation of Aldose-, Aldehyde- and a Renal Specific Oxido Reductase (RSOR) in the Pathobiology of Diabetes Mellitus
  323. Pelvic lymphocyst infection associated with maternally inherited diabetes mellitus
  324. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats
  325. Glomerular cell apoptosis in human lupus nephritis
  326. Successful treatment of necrotizing fasciitis associated with diabetic nephropathy
  327. Imprinted mesodermal specific transcript (MEST) and H19 genes in renal development and diabetes
  328. Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients
  329. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats
  330. Remission and Regression of Diabetic Nephropathy
  331. Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats
  332. Daily walking reduces visceral adipose tissue areas and improves insulin resistance in Japanese obese subjects
  333. A case of congenital generalized lipodystrophy with lipoatrophic diabetes developing anti‐insulin antibodies
  334. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats
  335. Isolation and Functional Analysis of Mouse UbA52 Gene and Its Relevance to Diabetic Nephropathy
  336. Therapeutic effect of sulphated hyaluronic acid, a potential selectin‐blocking agent, on experimental progressive mesangial proliferative glomerulonephritis
  337. Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis
  338. Identification of developmentally regulated mesodermal-specific transcript in mouse embryonic metanephros
  339. Renal Gene Expression in Embryonic and Newborn Diabetic Mice
  340. Relevance of renal-specific oxidoreductase in tubulogenesis during mammalian nephron development
  341. Angiocentric immunoproliferative lesions of the lung associated with diffuse renal involvement
  342. Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men
  343. Cyanotic congenital heart disease associated with glomerulomegaly and focal segmental glomerulosclerosis: remission of nephrotic syndrome with angiotensin converting enzyme inhibitor
  344. Gene expression and identification of gene therapy targets in diabetic nephropathy
  345. 内科  100年のあゆみ  腎臓 III  主要疾患の歴史 8  こう原病・血管炎
  346. Minimal Change Nephrotic Syndrome Developing during Postoperative Interferon-Beta Therapy for Malignant Melanoma
  347. Identification of up-regulated Ras-like GTPase, Rap1b, by suppression subtractive hybridization
  348. Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes
  349. Collectrin, a Collecting Duct-specific Transmembrane Glycoprotein, Is a Novel Homolog of ACE2 and Is Developmentally Regulated in Embryonic Kidneys
  350. Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis
  351. 糖尿病性腎症の診断と治療
  352. RELEVANCE OF ALDO-KETO REDUCTASE FAMILY MEMBERS TO THE PATHOBIOLOGY OF DIABETIC NEPHROPATHY AND RENAL DEVELOPMENT
  353. STATUS OF GLUCOSE TRANSPORTERS IN THE MAMMALIAN KIDNEY AND RENAL DEVELOPMENT
  354. The Necessity of Renal Biopsies in the Management of Diabetic Nephropathy
  355. Ultrastructure of Glomerular Basement Membrane in Active Heymann Nephritis Rats Revealed by Tissue-Negative Staining Method
  356. Successful use of cyclosporin A for the treatment of acute interstitial pneumonitis associated with rheumatoid arthritis
  357. Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats
  358. Expression characteristics and relevance of sodium glucose cotransporter-1 in mammalian renal tubulogenesis
  359. Familial interstitial nephritis with progressive renal failure
  360. Re-evaluation of exercise prescription for Japanese type 2 diabetic patients by ventilatory threshold
  361. Identification of a renal-specific oxido-reductase in newborn diabetic mice
  362. Clinical evaluation of muscle strength in 20–79-years-old obese Japanese
  363. Malignant Hypertension with a Rare Complication of Pulmonary Alveolar Hemorrhage
  364. Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis
  365. Novel approaches to unravel the genesis of glomerulosclerosis by new methodologies in molecular biology and molecular genetics
  366. Tubulointerstitial nephritis antigen: An extracellular matrix protein that selectively regulates tubulogenesis vs. glomerulogenesis during mammalian renal development
  367. Cloning of Rat Fibrillin-2 cDNA and Its Role in Branching Morphogenesis of Embryonic Lung
  368. Integrins Mediate the Inhibitory Effect of Focal Adhesion on Angiotensin II-Induced p44/42 Mitogen-Activated Protein (MAP) Kinase Activity in Human Mesangial Cells
  369. Screening for genes up-regulated in 5/6 nephrectomized mouse kidney
  370. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli
  371. Signaling Transduction Pathway of Angiotensin II in Human Mesangial Cells: Mediation of Focal Adhesion and GTPase Activating Proteins
  372. Differential Distribution of Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Proteins in Experimental Diabetic Rat Kidney
  373. Increased Urinary Excretion of Macrophage-Colony-Stimulating Factor (M-CSF) in Patients with IgA Nephropathy: Tonsil Stimulation Enhances Urinary M-CSF Excretion
  374. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy
  375. Isolation of rat fibrillin-1 cDNA and its relevance in metanephric development
  376. Relevance of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis
  377. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor
  378. Ultrastructure of mesangial type III collagen deposition in a patient with IgA nephropathy
  379. Therapeutic effects of prostacyclin analog on crescentic glomerulonephritis of rat
  380. Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney
  381. A Case of Membranous Nephropathy Associated with Psoriasis vulgaris
  382. Deposition of Mannan Binding Protein and Mannan Binding Protein-Mediated Complement Activation in the Glomeruli of Patients with IgA Nephropathy
  383. Fatal Hyperammonemia in a Patient with Systemic Lupus Erythematosus.
  384. Developmental regulation and partial-length cloning of tubulointerstitial nephritis antigen of murine metanephros
  385. Role of extracellular matrix, growth factors and proto-oncogenes in metanephric development
  386. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.
  387. Representational difference analysis of cDNA of genes expressed in embryonic kidney
  388. Identification and Characterization of Galectin-9, a Novel β-Galactoside-binding Mammalian Lectin
  389. D-glucose-induced dysmorphogenesis of embryonic kidney.
  390. Comparative Role of Phosphotyrosine Kinase Domains ofc-rosandc-retProtooncogenes in Metanephric Development with Respect to Growth Factors and Matrix Morphogens
  391. Cloning of mouse integrin alphaV cDNA and role of the alphaV-related matrix receptors in metanephric development.
  392. The Critical Role of Intercellular Adhesion Molecule-1 in Masugi Nephritis in Rats
  393. Cloning of mouse c-ros renal cDNA, its role in development and relationship to extracellular matrix glycoproteins
  394. Distribution of extracellular matrix receptors in various forms of glomerulonephritis
  395. Activation of complement during hemodialysis.
  396. Immunoreactivity of the JK-132 monoclonal antibody directed against basement membrane collagen in normal and diabetic glomeruli
  397. Localization of Fibril/Microfibril and Basement Membrane Collagens in Diabetic Glomerulosclerosis in Type 2 Diabetes
  398. Distribution and relevance of insulin-like growth factor-I receptor in metanephric development
  399. Cloning of cDNA for the alpha subunit of mouse insulin-like growth factor I receptor and the role of the receptor in metanephric development.
  400. A case of neutro-Behcet's disease started with diplopia.